| Symbol | NAUT |
|---|---|
| Name | NAUTILUS BIOTECHNOLOGY, INC. |
| Sector | INDUSTRIALS |
| Region | North America |
| Industry | Biotechnology: Laboratory Analytical Instruments |
| Address | 2701 EASTLAKE AVENUE EAST, SEATTLE, Washington, 98102, United States |
| Telephone | +1 206 333-2001 |
| Fax | — |
| — | |
| Website | https://www.nautilus.bio |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001808805 |
| Description | With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Additional info from NASDAQ: |
New Form SCHEDULE 13D/A - Nautilus Biotechnology, Inc. <b>Filed:</b> 2026-08-14 <b>AccNo:</b> 0001193125-26-352644 <b>Size:</b> 10 KB
Read moreNautilus Biotechnology to Announce Second Quarter 2026 Financial Results on July 28, 2026
Read moreNew Form SCHEDULE 13D/A - Nautilus Biotechnology, Inc. <b>Filed:</b> 2026-06-30 <b>AccNo:</b> 0001725721-26-000004 <b>Size:</b> 18 KB
Read moreDirector Posard Matthew L. 🟢 acquired 45.0K shares (1 derivative) of Nautilus Biotechnology, Inc. (NAUT) at $2.28 Transaction Date: Jun 18, 2026 | Filing ID: 000002
Read moreDirector NAZEM FARZAD 🟢 acquired 45.0K shares (1 derivative) of Nautilus Biotechnology, Inc. (NAUT) at $2.28 Transaction Date: Jun 18, 2026 | Filing ID: 000002
Read moreDirector Akinsanya Karen 🟢 acquired 45.0K shares (1 derivative) of Nautilus Biotechnology, Inc. (NAUT) at $2.28 Transaction Date: Jun 18, 2026 | Filing ID: 000004
Read moreDirector McIlwain Matthew S 🟢 acquired 45.0K shares (1 derivative) of Nautilus Biotechnology, Inc. (NAUT) at $2.28 Transaction Date: Jun 18, 2026 | Filing ID: 000001
Read moreDirector Epperly Melissa B, 🟢 acquired 45.0K shares (1 derivative) of Nautilus Biotechnology, Inc. (NAUT) at $2.28 Transaction Date: Jun 18, 2026 | Filing ID: 000008
Read moreAH Equity Partners Bio II, L.L.C. 🔴 sold 5.0M shares of Nautilus Biotechnology, Inc. (NAUT) at $2.35 ($11.8M) Transaction Date: Jun 02, 2026 | Filing ID: 000599
Read moreNew Form SCHEDULE 13D/A - Nautilus Biotechnology, Inc. <b>Filed:</b> 2026-06-04 <b>AccNo:</b> 0001725721-26-000002 <b>Size:</b> 37 KB
Read more